Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Indivior Pharmaceuticals (INDV) Receivables - Other (2023 - 2025)

Indivior Pharmaceuticals has reported Receivables - Other over the past 3 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Receivables - Other at $2.0 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $2.0 million (changed 0.0% YoY), and the annual figure for FY2025 was $2.0 million, changed 0.0%.
  • Receivables - Other for Q4 2025 was $2.0 million at Indivior Pharmaceuticals, roughly flat from $2.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for INDV hit a ceiling of $2.0 million in Q4 2024 and a floor of $1.0 million in Q4 2023.
  • Median Receivables - Other over the past 3 years was $2.0 million (2024), compared with a mean of $1.7 million.
  • Biggest five-year swings in Receivables - Other: skyrocketed 100.0% in 2024 and later changed 0.0% in 2025.
  • Indivior Pharmaceuticals' Receivables - Other stood at $1.0 million in 2023, then skyrocketed by 100.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
  • The last three reported values for Receivables - Other were $2.0 million (Q4 2025), $2.0 million (Q4 2024), and $1.0 million (Q4 2023) per Business Quant data.